From the Departments of Radiation Oncology (B.
Malignant lymphoma after diphenylhydantoin (dilantin) therapy
β Scribed by Frederick P. Li; Douglas R. Willard; Robert Goodman; Gordon Vawter
- Publisher
- John Wiley and Sons
- Year
- 1975
- Tongue
- English
- Weight
- 336 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A combination of intravenous cyclophosphamide and vincristine (Oncovin) and oral prednisone (COP) was given every 2 weeks to 262 patients with disseminated Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma, a n d follicular lymphoma. A complete remission was produced in 36% of patients with H
## Abstract ## Background Sex hormone deficiency, growth hormone deficiency, skeletal irradiation, and treatment with corticosteroids or methotrexate may all cause reduction in bone mass after treatment for childhood malignant lymphoma. Previous studies of the bone mass of childhood cancer survivo